Piperidine derivatives as CCR5 inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7399771
APP PUB NO 20060004047A1
SERIAL NO

10529776

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are compounds of formula I: ##STR00001## wherein R.sub.1, R.sub.2, R.sub.3 and X are as defined herein, in free or salt form, which are useful as CCR5 inhibitors, e.g. in the prevention or treatment of disorders mediated by interactions between chemokine receptors and their ligands.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NOVARTIS AG

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Albert, Rainer Basel, CH 40 365
Bruns, Christian Freiburg, DE 23 171
Cooke, Nigel Graham Oberwil, CH 33 281
Nuninger, Francois Wittenheim, FR 5 10
Streiff, Markus Birsfelden, CH 7 66
Thoma, Gebhard Lorrach, DE 27 429
Zerwes, Hans-Gunter Lorrach, DE 11 48

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation